Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Xenon Pharmaceuticals missed estimated earnings by 29.73%, reporting an EPS of $-0.48 versus an estimate of $-0.37.
Revenue was up $1.41 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 6.21% drop in the share price the next day.
Here's a look at Xenon Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.38 | -0.48 | -0.40 | -0.40 |
| EPS Actual | -0.36 | -0.51 | -0.42 | -0.34 |
| Revenue Estimate | 10.22M | 2.33M | 5.15M | 3.22M |
| Revenue Actual | 8.12M | 2.22M | 4.36M | 5.15M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
